Interest Expense of BIO KEY INTERNATIONAL INC from 30 Jun 2010 to 31 Mar 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of the cost of borrowed funds accounted for as interest expense.
Summary: BIO KEY INTERNATIONAL INC quarterly and annual Interest Expense in USD history and change rate from 30 Jun 2010 to 31 Mar 2024.
BIO KEY INTERNATIONAL INC Interest Expense for the quarter ending 31 Mar 2024 was $1,356, a 98% decline year-over-year.
BIO KEY INTERNATIONAL INC Interest Expense for the twelve months ending 31 Mar 2024 was $162,707, a 141% increase year-over-year.
BIO KEY INTERNATIONAL INC annual Interest Expense for 2023 was $218,270, a 1986% increase from 2022.
BIO KEY INTERNATIONAL INC annual Interest Expense for 2022 was $10,462, a 42% decline from 2021.
BIO KEY INTERNATIONAL INC annual Interest Expense for 2021 was $18,000, a 100% decline from 2020.
Source SEC data: View on sec.gov

Interest Expense, Trailing 12 Months (USD)

Interest Expense, Quarterly (USD)

Interest Expense, YoY Quarterly Change (%)

Interest Expense, Annual (USD)

Interest Expense, YoY Annual Change (%)

BIO KEY INTERNATIONAL INC Quarterly Interest Expense (USD)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2024	$162,707	$1,356	-$55,563	-98%	01 Jan 2024	31 Mar 2024	10-Q	14 Jun 2024	2024	Q1
Q4 2023	$218,270	$58,890	+$52,039	+760%	01 Oct 2023	31 Dec 2023	10-K	05 Jun 2024	2023	FY
Q3 2023	$166,231	$45,655	+$43,584	+2104%	01 Jul 2023	30 Sep 2023	10-Q	20 Nov 2023	2023	Q3
Q2 2023	$122,647	$56,806	+$55,266	+3589%	01 Apr 2023	30 Jun 2023	10-Q	18 Aug 2023	2023	Q2
Q1 2023	$67,381	$56,919	+$56,919		01 Jan 2023	31 Mar 2023	10-Q	14 Jun 2024	2024	Q1
Q4 2022	$10,462	$6,851	+$6,851		01 Oct 2022	31 Dec 2022	10-K	05 Jun 2024	2023	FY
Q3 2022	$3,611	$2,071	+$2,071		01 Jul 2022	30 Sep 2022	10-Q	20 Nov 2023	2023	Q3
Q2 2022	$1,540	$1,540	+$1,540		01 Apr 2022	30 Jun 2022	10-Q	18 Aug 2023	2023	Q2
Q1 2022	$0	$0	-$18,000	-100%	01 Jan 2022	31 Mar 2022	10-Q	09 Jun 2023	2023	Q1
Q4 2021	$18,000	$0	-$19,635	-100%	01 Oct 2021	31 Dec 2021	10-K	01 Jun 2023	2022	FY
Q3 2021	$37,635	$0	-$2,204,920	-100%	01 Jul 2021	30 Sep 2021	10-Q	14 Nov 2022	2022	Q3
Q2 2021	$2,242,555	$0	-$567,516	-100%	01 Apr 2021	30 Jun 2021	10-Q	17 Aug 2022	2022	Q2
Q1 2021	$2,810,071	$18,000	-$1,533,141	-99%	01 Jan 2021	31 Mar 2021	10-Q	23 May 2022	2022	Q1
Q4 2020	$4,343,212	$19,635			01 Oct 2020	31 Dec 2020	10-K	01 Apr 2022	2021	FY
Q3 2020		$2,204,920	+$1,646,471	+295%	01 Jul 2020	30 Sep 2020	10-Q	15 Nov 2021	2021	Q3
Q2 2020		$567,516	+$452,650	+394%	01 Apr 2020	30 Jun 2020	10-Q	16 Aug 2021	2021	Q2
Q1 2020		$1,551,141			01 Jan 2020	31 Mar 2020	10-Q	17 May 2021	2021	Q1
Q3 2019		$558,449			01 Jul 2019	30 Sep 2019	10-Q	16 Nov 2020	2020	Q3
Q2 2019		$114,866			01 Apr 2019	30 Jun 2019	10-Q	14 Aug 2020	2020	Q2
Q4 2015	$192,199	$172,203			01 Oct 2015	31 Dec 2015	10-K/A	04 Apr 2017	2016	FY
Q3 2015		$20,000	+$20,002		01 Jul 2015	30 Sep 2015	10-Q	14 Nov 2016	2016	Q3
Q2 2015		$2^*	$0		01 Apr 2015	30 Jun 2015	10-Q	14 Aug 2015	2015	Q2
Q1 2015		$2^*	$0		01 Jan 2015	31 Mar 2015	10-Q	14 May 2015	2015	Q1
Q3 2014	$100,364	$2^*	-$13,944		01 Jul 2014	30 Sep 2014	10-Q	14 Nov 2014	2014	Q3
Q2 2014	$114,308	$2^*	-$14,650		01 Apr 2014	30 Jun 2014	10-Q	14 Aug 2015	2015	Q2
Q1 2014	$128,958	$2^*	-$7,526		01 Jan 2014	31 Mar 2014	10-Q	14 May 2015	2015	Q1
Q4 2013	$136,484	$100,370	+$88,115	+719%	01 Oct 2013	31 Dec 2013	10-K	31 Mar 2015	2014	FY
Q3 2013	$48,369	$13,942	+$7,748	+125%	01 Jul 2013	30 Sep 2013	10-Q	14 Nov 2014	2014	Q3
Q2 2013	$40,621	$14,648	+$8,521	+139%	01 Apr 2013	30 Jun 2013	10-Q	14 Aug 2014	2014	Q2
Q1 2013	$32,100	$7,524	+$1,396	+23%	01 Jan 2013	31 Mar 2013	10-Q	12 May 2014	2014	Q1
Q4 2012	$30,704	$12,255	+$6,057	+98%	01 Oct 2012	31 Dec 2012	10-Q	14 Aug 2013	2013	Q2
Q3 2012	$24,647	$6,194	-$3	-0.05%	01 Jul 2012	30 Sep 2012	10-Q	14 Nov 2013	2013	Q3
Q2 2012	$24,650	$6,127	-$284,956	-98%	01 Apr 2012	30 Jun 2012	10-Q	14 Aug 2013	2013	Q2
Q1 2012	$309,606	$6,128	-$101,921	-94%	01 Jan 2012	31 Mar 2012	10-Q	15 May 2013	2013	Q1
Q4 2011	$411,527	$6,198			01 Oct 2011	31 Dec 2011	10-K	01 Apr 2013	2012	FY
Q3 2011		$6,197	-$199,251	-97%	01 Jul 2011	30 Sep 2011	10-Q	19 Nov 2012	2012	Q3
Q2 2011		$291,083	+$126,736	+77%	01 Apr 2011	30 Jun 2011	10-Q	14 Aug 2012	2012	Q2
Q1 2011		$108,049			01 Jan 2011	31 Mar 2011	10-Q	11 May 2012	2012	Q1
Q3 2010		$205,448			01 Jul 2010	30 Sep 2010	10-Q	14 Nov 2011	2011	Q3
Q2 2010		$164,347			01 Apr 2010	30 Jun 2010	10-Q	15 Aug 2011	2011	Q2

BIO KEY INTERNATIONAL INC Annual Interest Expense (USD)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2023	$218,270	+$207,808	+1986%	01 Jan 2023	31 Dec 2023	10-K	05 Jun 2024	2023	FY
2022	$10,462	-$7,538	-42%	01 Jan 2022	31 Dec 2022	10-K	05 Jun 2024	2023	FY
2021	$18,000	-$4,325,212	-100%	01 Jan 2021	31 Dec 2021	10-K	01 Jun 2023	2022	FY
2020	$4,343,212	+$3,274,078	+306%	01 Jan 2020	31 Dec 2020	10-K	01 Apr 2022	2021	FY
2019	$1,069,134			01 Jan 2019	31 Dec 2019	10-K	29 Mar 2021	2020	FY
2015	$192,199			01 Jan 2015	31 Dec 2015	10-K/A	04 Apr 2017	2016	FY
2013	$136,484	+$111,858	+454%	01 Jan 2013	31 Dec 2013	10-K	31 Mar 2015	2014	FY
2012	$24,626	-$386,901	-94%	01 Jan 2012	31 Dec 2012	10-K	31 Mar 2014	2013	FY
2011	$411,527	-$299,821	-42%	01 Jan 2011	31 Dec 2011	10-K	01 Apr 2013	2012	FY
2010	$711,348			01 Jan 2010	31 Dec 2010	10-K	16 Apr 2012	2011	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.